Chloride intracellular channel protein 2 (CLIC2)

Chloride intracellular channel protein 2 (CLIC2) is a member of the CLIC family of proteins, primarily functioning as an intracellular chloride channel and collagen-modulating enzyme. It can exist both as a soluble cytoplasmic enzyme with glutaredoxin-like activity and as a membrane-associated ion channel. CLIC2 is involved in the regulation of ryanodine receptor 2 (RYR2), thereby modulating intracellular calcium release, and is essential for endothelial tight junction maintenance. It is uniquely secreted into the extracellular space, where it binds and inhibits MMP14, suppressing tumor cell invasion and metastasis by preventing degradation of the extracellular matrix. Mutations in CLIC2 are associated with X-linked intellectual disability and cardiovascular syndromes. CLIC2 is considered a potential therapeutic target in oncology for its tumor-suppressive properties, particularly its role in reducing hematogenous spread of cancer cells. CLIC2 is expressed in various organs, with high expression in normal vascular endothelium and low or absent expression in the vasculature of malignant tumors[2][3][4][9]. Caveats: No approved drugs currently target CLIC2 directly in clinical practice as of the latest evidence[2][6]. Most disease associations relate to its loss or mutation, not overactivity. Its full mechanism in ion channel activity versus protein-protein interaction (e.g., with MMP14) remains an active field of research.

Other names

CLIC2CLIC-2Chloride channel 2Chloride intracellular channel 2p64HXpterpter

Inhibition of ryanodine receptor 2 (RYR2) function, reducing calcium release from intracellular stores[1][7]. Inhibition of matrix metalloproteinase 14 (MMP14), which then suppresses MMP2, impeding tumor cell invasion and metastasis[2][9]. Potential regulation of endothelial tight junction integrity to prevent tumor cell intravasation[3].